Evidence map›Paper›PMID 18367522›Full record

ArticleJournal of virology2008

Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV.

Chae-ryun Yi, Naomi Rosenberg

Abstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chae-ryun YiMolecular Microbiology Graduate Program, Sackler School of Graduate Biomedical Sciences, Boston, Massachusetts 02111, USA.
Naomi Rosenberg
Tufts University · US

Funding

RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONSR01CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1985 to 2007
$2.6M
ABELSON LEUKEMIA VIRUS TRANSFORMATIONR01CA024220 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1985 to 2005
$1.8M
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTIONR37CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1993 to 1997
–
NCI NIH HHS CA24220NCI NIH HHS CA33771NCI NIH HHS R01 CA024220NCI NIH HHS R01 CA033771
6 · The paper itself

Abstract

Abelson murine leukemia virus (Ab-MLV) arose from a recombination between gag sequences in Moloney MLV (Mo-MLV) and the c-abl proto-oncogene. The v-Abl oncoprotein encoded by Ab-MLV contains MA, p12, and a portion of CA sequences derived from the gag gene of Mo-MLV. Previous studies indicated that alteration of MA sequences affects the biology of Mo-MLV and Ab-MLV. To understand the role of these sequences in Ab-MLV transformation more fully, alanine substitution mutants that affect Mo-MLV replication were examined in the context of Ab-MLV. Mutations affecting Mo-MLV replication decreased transformation, while alanine mutations in residues dispensable for Mo-MLV replication did not. The altered v-Abl proteins displayed aberrant subcellular localization that correlated to transformation defects. Immunofluorescent analyses suggested that aberrant trafficking of the altered proteins and improper interaction with components of the cytoskeleton were involved in the phenotype. Similar defects in localization were observed when the Gag moiety containing these mutations was expressed in the absence of abl-derived sequences. These results indicate that MA sequences within the Gag moiety of the v-Abl protein contribute to proper localization by playing a dominant role in trafficking of the v-Abl molecule.

Indexed as

Abelson murine leukemia virusAmino Acid SequenceBinding SitesCrystallography, X-RayDimerizationGene Products, gagModels, MolecularMolecular Sequence DataMoloney murine leukemia virusMutationOligosaccharidesOncogene Proteins v-ablPeptidesProtein Structure, QuaternaryProtein Structure, TertiarySequence AlignmentGene Products, gagOligosaccharidesOncogene Proteins v-ablPeptides

Identifiers

PMID18367522
PMCPMC2395225
OpenAlexW2112300867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.